BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 29880787)

  • 1. Upregulation of KIF26B, Cell Migration and Proliferation of Human Ovarian Cancer Cell Lines In Vitro, and Patient Outcomes from Human Bioinformatic Analysis.
    Yang X; Zhang L; Xie L
    Med Sci Monit; 2018 Jun; 24():3863-3872. PubMed ID: 29880787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. KIF26B promotes cell proliferation and migration through the FGF2/ERK signaling pathway in breast cancer.
    Teng Y; Guo B; Mu X; Liu S
    Biomed Pharmacother; 2018 Dec; 108():766-773. PubMed ID: 30248545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated kinesin family member 26B is a prognostic biomarker and a potential therapeutic target for colorectal cancer.
    Wang J; Cui F; Wang X; Xue Y; Chen J; Yu Y; Lu H; Zhang M; Tang H; Peng Z
    J Exp Clin Cancer Res; 2015 Feb; 34(1):13. PubMed ID: 25652119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High WAVE3 expression correlates with proliferation, migration and invasion in human ovarian cancer.
    Lu J; Wang SL; Wang YC; Wu YN; Yu X; Zhao WZ; Wang JH
    Oncotarget; 2017 Jun; 8(25):41189-41201. PubMed ID: 28476025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B7-H3 is related to tumor progression in ovarian cancer.
    Zhang J; Liu L; Han S; Li Y; Qian Q; Zhang Q; Zhang H; Yang Z; Zhang Y
    Oncol Rep; 2017 Oct; 38(4):2426-2434. PubMed ID: 28765941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SNORD89 promotes stemness phenotype of ovarian cancer cells by regulating Notch1-c-Myc pathway.
    Zhu W; Niu J; He M; Zhang L; Lv X; Liu F; Jiang L; Zhang J; Yu Z; Zhao L; Bi J; Yan Y; Wei Q; Huo H; Fan Y; Chen Y; Ding J; Wei M
    J Transl Med; 2019 Aug; 17(1):259. PubMed ID: 31395064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Succinate dehydrogenase subunit B inhibits the AMPK-HIF-1α pathway in human ovarian cancer in vitro.
    Chen L; Liu T; Zhang S; Zhou J; Wang Y; Di W
    J Ovarian Res; 2014 Dec; 7():115. PubMed ID: 25491408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-223-3p Regulates Ovarian Cancer Cell Proliferation and Invasion by Targeting SOX11 Expression.
    Fang G; Liu J; Wang Q; Huang X; Yang R; Pang Y; Yang M
    Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28587313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer-associated fibroblasts secrete FGF-1 to promote ovarian proliferation, migration, and invasion through the activation of FGF-1/FGFR4 signaling.
    Sun Y; Fan X; Zhang Q; Shi X; Xu G; Zou C
    Tumour Biol; 2017 Jul; 39(7):1010428317712592. PubMed ID: 28718374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NFATc1 regulates cell proliferation, migration, and invasion of ovarian cancer SKOV3 cells in vitro and in vivo.
    Li L; Duan Z; Yu J; Dang HX
    Oncol Rep; 2016 Aug; 36(2):918-28. PubMed ID: 27350254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinesin Family Member C1 (KIFC1) Regulated by Centrosome Protein E (CENPE) Promotes Proliferation, Migration, and Epithelial-Mesenchymal Transition of Ovarian Cancer.
    Li J; Diao H; Guan X; Tian X
    Med Sci Monit; 2020 Dec; 26():e927869. PubMed ID: 33361741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DDA1 is induced by NR2F6 in ovarian cancer and predicts poor survival outcome.
    Liu J; Li T; Liu XL
    Eur Rev Med Pharmacol Sci; 2017 Mar; 21(6):1206-1213. PubMed ID: 28387912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibin resistance is associated with aggressive tumorigenicity of ovarian cancer cells.
    Steller MD; Shaw TJ; Vanderhyden BC; Ethier JF
    Mol Cancer Res; 2005 Jan; 3(1):50-61. PubMed ID: 15671249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DKC1 serves as a potential prognostic biomarker for human clear cell renal cell carcinoma and promotes its proliferation, migration and invasion via the NF‑κB pathway.
    Zhang M; Pan Y; Jiang R; Hou P; Shan H; Chen F; Jiang T; Bai J; Zheng J
    Oncol Rep; 2018 Aug; 40(2):968-978. PubMed ID: 29901172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upregulation of
    Wu L; Ling ZH; Wang H; Wang XY; Gui J
    Cancer Biother Radiopharm; 2019 Dec; 34(10):642-649. PubMed ID: 31549859
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical value of survivin and its underlying mechanism in ovarian cancer: A bioinformatics study based on GEO and TCGA data mining.
    Li XJ; Pang JS; Li YM; Ahmed FA; He RQ; Ma J; Ma FC; Chen G
    Pathol Res Pract; 2018 Mar; 214(3):385-401. PubMed ID: 29499854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-335 represents an invasion suppressor gene in ovarian cancer by targeting Bcl-w.
    Cao J; Cai J; Huang D; Han Q; Yang Q; Li T; Ding H; Wang Z
    Oncol Rep; 2013 Aug; 30(2):701-6. PubMed ID: 23708561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioinformatic Analysis of GLI1 and Related Signaling Pathways in Chemosensitivity of Gastric Cancer.
    Yu T; Jia W; An Q; Cao X; Xiao G
    Med Sci Monit; 2018 Mar; 24():1847-1855. PubMed ID: 29596399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of Key Candidate Genes and Pathways for Relationship between Ovarian Cancer and Diabetes Mellitus Using Bioinformatical Analysis.
    Sun Y; Xiaoyan H; Yun L; Chaoqun L; Jialing W; Liu Y; Yingqi Z; Peipei Y; Junjun P; Yuanming L
    Asian Pac J Cancer Prev; 2019 Jan; 20(1):145-155. PubMed ID: 30678426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic roles of Notch receptor mRNA expression in human ovarian cancer.
    Chen C; Wang X; Huang S; Wang L; Han L; Yu S
    Oncotarget; 2017 May; 8(20):32731-32740. PubMed ID: 28415574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.